Explore / Clinical trial
Clinical trial

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Stanford UniversityRecruitingPhase 2Started Feb 24, 2024150 enrolledUnited StatesNCT05940324

Abstract

The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineOCD

Keywords

NaltrexoneMRIBrain ImagingOCD symptomsObsessive-Compulsive DisorderObsessive-Compulsive Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.